Victory Capital Management Inc Royalty Pharma PLC Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Victory Capital Management Inc holds 849,035 shares of RPRX stock, worth $21.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

849,035

Previous 669,624 26.79%

Holding current value

$21.3 Million

Previous $17.7 Million 36.03%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$25.63 - $29.27 $4.6 Million - $5.25 Million	179,411 Added 26.79%	849,035 $24 Million
Q2 2024 Aug 05, 2024	BUY	$26.26 - $29.9 $5.54 Million - $6.31 Million	211,131 Added 46.05%	669,624 $17.7 Million
Q1 2024 May 03, 2024	BUY	$27.46 - $31.33 $5.29 Million - $6.04 Million	192,782 Added 72.55%	458,493 $13.9 Million
Q4 2023 Feb 05, 2024	SELL	$26.21 - $29.22 $1.92 Million - $2.14 Million	-73,179 Reduced 21.59%	265,711 $7.46 Million
Q3 2023 Nov 06, 2023	BUY	$26.26 - $31.38 $757,627 - $905,344	28,851 Added 9.31%	338,890 $9.2 Million
Q2 2023 Jul 27, 2023	BUY	$29.6 - $36.56 $709,216 - $875,977	23,960 Added 8.38%	310,039 $9.53 Million
Q1 2023 May 02, 2023	BUY	$32.77 - $39.4 $574,621 - $690,879	17,535 Added 6.53%	286,079 $10.3 Million
Q4 2022 Feb 10, 2023	SELL	$39.17 - $44.04 $44,144 - $49,633	-1,127 Reduced 0.42%	268,544 $10.6 Million
Q4 2022 Feb 09, 2023	BUY	$39.17 - $44.04 $405,331 - $455,725	10,348 Added 3.99%	269,671 $10.7 Million
Q3 2022 Nov 02, 2022	BUY	$39.88 - $44.65 $4.1 Million - $4.59 Million	102,847 Added 65.73%	259,323 $10.4 Million
Q2 2022 Aug 01, 2022	SELL	$37.53 - $44.22 $501,663 - $591,088	-13,367 Reduced 7.87%	156,476 $6.58 Million
Q1 2022 May 04, 2022	BUY	$37.46 - $42.44 $5.06 Million - $5.73 Million	135,102 Added 388.88%	169,843 $7.23 Million
Q4 2021 Feb 07, 2022	SELL	$35.17 - $42.48 $1.94 Million - $2.34 Million	-55,183 Reduced 61.37%	34,741 $1.38 Million
Q3 2021 Nov 02, 2021	SELL	$36.14 - $42.24 $42.1 Million - $49.2 Million	-1,164,574 Reduced 92.83%	89,924 $3.25 Million
Q2 2021 Aug 03, 2021	SELL	$39.85 - $46.63 $77.1 Million - $90.2 Million	-1,933,796 Reduced 60.65%	1,254,498 $51.4 Million
Q1 2021 May 04, 2021	SELL	$42.34 - $52.82 $22 Million - $27.4 Million	-519,438 Reduced 14.01%	3,188,294 $139 Million
Q4 2020 Feb 01, 2021	BUY	$36.12 - $50.05 $31.3 Million - $43.4 Million	866,849 Added 30.51%	3,707,732 $186 Million
Q3 2020 Nov 09, 2020	SELL	$38.56 - $48.36 $15.8 Million - $19.8 Million	-410,227 Reduced 12.62%	2,840,883 $120 Million
Q2 2020 Aug 07, 2020	BUY	$44.5 - $52.11 $145 Million - $169 Million	3,251,110 New	3,251,110 $158 Million

Others Institutions Holding RPRX

# of Institutions

414

Shares Held

283M

Call Options Held

578K

Put Options Held

47.5K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Royalty Pharma PLC Transaction History